Heterogeneity of the Baseline Risk within Patient Populations of Clinical Trials: A Proposed Evaluation Algorithm
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
In this paper, the authors present an evaluation algorithm for systematic assessment of the observed heterogeneity in disease risk within trial populations. Predictive models are used to estimate the predicted patient hazards, the odds of having an event in the upper risk quartile (ODU) and the lower risk quartile (ODL), and the odds ratio (rate ratio for time-to-event analyses) for having an event in the upper risk quartile versus the lower risk quartile (extreme quartile odds ratio (EQuOR) and extreme quartile rate ratio (EQuRR)). The ranges for these metrics depend on the extent to which predictors of the outcome of interest exist and are known and the extent to which data are collected in the trial, as well as on the eligibility criteria and the specific patients who are actually enrolled. ODU, ODL, and EQuOR values are used to systematically interpret the results for patients at different levels of risk, to evaluate generalizability, and to determine the need for subgroup analyses. Individual data for five outcomes from three trials (n = 842, 913, and 1,001, respectively) are used as examples. Observed EQuOR values ranged from 1.5 (very little predicted heterogeneity) to 59 (large heterogeneity). EQuRR values ranged from 2 to 46. ODU values ranged from 0.24 to 3.19 (generally high risk), and ODL values ranged from 0.01 (clinically negligible risk) to 0.16 (clinically meaningful risk). The algorithm may also be used for comparing diverse trials (e.g., in meta-analyses) and used prospectively for designing future trials, as shown in simulations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A note on a general definition of the coefficient of determination
NAGELKERKE, N. J. D. (1991) · Biometrika · doi:10.1093/biomet/78.3.691 · Cited by 5,927 · cited 2×
“Rc (2), corrected coefficient of determination, given by the ratio of R(2) to the maximum possible R(2) (18); the maximum possible R(2) is given by 1 - exp[2LL(,/n], where LL0 is the log likelihood of a model without any predictors (18).”
Yusuf, S. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03470010097038 · Cited by 1,014 · cited 1×
“Subgroup analyses are often viewed with justifiable skepticism given their low power and the difficulty of validating them (27, 28).”
A consumer's guide to subgroup analyses
Oxman, A. D., & Guyatt, G. H. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-1-78 · Cited by 914 · cited 1×
“Subgroup analyses are often viewed with justifiable skepticism given their low power and the difficulty of validating them (27, 28).”
Large Trials vs Meta-analysis of Smaller Trials: How Do Their Results Compare?
Cappelleri, J. C. (1996) · JAMA · doi:10.1001/jama.1996.03540160054033 · Cited by 336
Cited by
Interpretation of tests of heterogeneity and bias in meta-analysis
Ioannidis, J. P. A. (2008) · Journal of Evaluation in Clinical Practice · doi:10.1111/j.1365-2753.2008.00986.x · Cited by 696
Savović, J., Jones, H., Altman, D., Harris, R., Jűni, P., Pildal, J., Als-Nielsen, B., Balk, E., Gluud, C., Gluud, L., et al. (2012) · Health Technology Assessment · doi:10.3310/hta16350 · Cited by 668
Burr, J., Mowatt, G., Hernández, R., Siddiqui, M., Cook, J., Lourenco, T., Ramsay, C., Vale, L., Fraser, C., Azuara-Blanco, A., et al. (2007) · Health Technology Assessment · doi:10.3310/hta11410 · Cited by 549
Kent, D. M., & Hayward, R. A. (2007) · JAMA · doi:10.1001/jama.298.10.1209 · Cited by 505
Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal
Kent, D. M., Rothwell, P. M., Ioannidis, J. P., Altman, D. G., & Hayward, R. A. (2010) · Trials · doi:10.1186/1745-6215-11-85 · Cited by 504
Metadata
- Authors
- loannidis, J. P. A., & Lau, J.
- Venue
- American Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 1998-12-01
- Volume
- 148
- Issue
- 11
- Pages
- 1117-1126
- ISSN
- 0002-9262 (ISSN-L)
- 1476-6256
- OpenAlex
- W2090377930
- Cited by
- 72
- References
- 4
- FWCI
- 3.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Heterogeneity of the Baseline Risk within Patient Populations of Clinical Trials: A Proposed Evaluation Algorithm. https://app.cochat.ai/papers/10.1093/oxfordjournals.aje.a009590
- The paper
- loannidis, J. P. A., & Lau, J. (1998). Heterogeneity of the Baseline Risk within Patient Populations of Clinical Trials: A Proposed Evaluation Algorithm. American Journal of Epidemiology. https://doi.org/10.1093/oxfordjournals.aje.a009590
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.